These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26037468)

  • 1. Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and Adolescence.
    Dörffel W; Riepenhausenl M; Lüders H; Brämswig J; Schellong G
    Dtsch Arztebl Int; 2015 May; 112(18):320-7, i. PubMed ID: 26037468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up.
    Schellong G; Riepenhausen M; Ehlert K; Brämswig J; Dörffel W; ; Schmutzler RK; Rhiem K; Bick U;
    Dtsch Arztebl Int; 2014 Jan; 111(1-2):3-9. PubMed ID: 24565270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
    O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
    J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence.
    Green DM; Hyland A; Barcos MP; Reynolds JA; Lee RJ; Hall BC; Zevon MA
    J Clin Oncol; 2000 Apr; 18(7):1492-9. PubMed ID: 10735897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology.
    Sankila R; Garwicz S; Olsen JH; Döllner H; Hertz H; Kreuger A; Langmark F; Lanning M; Möller T; Tulinius H
    J Clin Oncol; 1996 May; 14(5):1442-6. PubMed ID: 8622057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C; Veraguth A; Lütolf UM
    Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mortality after successful treatment for Hodgkin's disease.
    Hudson MM; Poquette CA; Lee J; Greenwald CA; Shah A; Luo X; Thompson EI; Wilimas JA; Kun LE; Crist WM
    J Clin Oncol; 1998 Nov; 16(11):3592-600. PubMed ID: 9817280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.
    Constine LS; Tarbell N; Hudson MM; Schwartz C; Fisher SG; Muhs AG; Basu SK; Kun LE; Ng A; Mauch P; Sandhu A; Culakova E; Lyman G; Mendenhall N
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):24-33. PubMed ID: 18722263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
    Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
    N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
    Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
    Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary malignancies in late periods after chemoradiotherapy for lymphogranulomatosis in children].
    Parkhomenko RA; Shcherbenko OI; Zelinskaia NI; Snigireva RIa; Khalil' EF; Ardatova GV; Chazova NL
    Vestn Rentgenol Radiol; 2008; (2-3):7-9. PubMed ID: 21337756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.
    Taylor AJ; Croft AP; Palace AM; Winter DL; Reulen RC; Stiller CA; Stevens MC; Hawkins MM
    Int J Cancer; 2009 Nov; 125(10):2400-5. PubMed ID: 19610069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.